JP2016540798A5 - - Google Patents

Download PDF

Info

Publication number
JP2016540798A5
JP2016540798A5 JP2016540038A JP2016540038A JP2016540798A5 JP 2016540798 A5 JP2016540798 A5 JP 2016540798A5 JP 2016540038 A JP2016540038 A JP 2016540038A JP 2016540038 A JP2016540038 A JP 2016540038A JP 2016540798 A5 JP2016540798 A5 JP 2016540798A5
Authority
JP
Japan
Prior art keywords
opioid
active ingredient
pharmacologically active
nsaid
cox
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016540038A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016540798A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2014/077748 external-priority patent/WO2015091352A1/en
Publication of JP2016540798A publication Critical patent/JP2016540798A/ja
Publication of JP2016540798A5 publication Critical patent/JP2016540798A5/ja
Pending legal-status Critical Current

Links

JP2016540038A 2013-12-16 2014-12-15 共押出により製造される、二峰性放出プロファイルを有する改変防止（ｔａｍｐｅｒ ｒｅｓｉｓｔａｎｔ）剤形 Pending JP2016540798A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13197503.9 2013-12-16
EP13197503 2013-12-16
PCT/EP2014/077748 WO2015091352A1 (en) 2013-12-16 2014-12-15 Tamper resistant dosage form with bimodal release profile manufactured by co-extrusion

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019107622A Division JP2019172688A (ja) 2013-12-16 2019-06-10 共押出により製造される、二峰性放出プロファイルを有する改変防止（ｔａｍｐｅｒ ｒｅｓｉｓｔａｎｔ）剤形

Publications (2)

Publication Number Publication Date
JP2016540798A JP2016540798A (ja) 2016-12-28
JP2016540798A5 true JP2016540798A5 (enExample) 2018-12-06

Family

ID=49882823

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016540038A Pending JP2016540798A (ja) 2013-12-16 2014-12-15 共押出により製造される、二峰性放出プロファイルを有する改変防止（ｔａｍｐｅｒ ｒｅｓｉｓｔａｎｔ）剤形
JP2019107622A Withdrawn JP2019172688A (ja) 2013-12-16 2019-06-10 共押出により製造される、二峰性放出プロファイルを有する改変防止（ｔａｍｐｅｒ ｒｅｓｉｓｔａｎｔ）剤形

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2019107622A Withdrawn JP2019172688A (ja) 2013-12-16 2019-06-10 共押出により製造される、二峰性放出プロファイルを有する改変防止（ｔａｍｐｅｒ ｒｅｓｉｓｔａｎｔ）剤形

Country Status (7)

Country Link
US (3) US20150164807A1 (enExample)
EP (1) EP3082781A1 (enExample)
JP (2) JP2016540798A (enExample)
AU (1) AU2014365038B2 (enExample)
CA (1) CA2933983A1 (enExample)
MX (1) MX2016007848A (enExample)
WO (1) WO2015091352A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201502077D0 (en) * 2015-02-09 2015-03-25 Cubic Pharmaceuticals Ltd And Delta Pharmaceuticals Ltd Improved hme technology

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3612211A1 (de) 1986-04-11 1987-10-15 Basf Ag Kontinuierliches verfahren zum tablettieren
DE19710008A1 (de) * 1997-03-12 1998-09-17 Basf Ag Feste, mindestens zweiphasige Zubereitungsformen eines Opioid-Analgeticums mit verzögerter Freisetzung
AU3024399A (en) 1998-04-03 1999-10-25 Bm Research A/S Controlled release composition
US7141250B2 (en) 2001-08-06 2006-11-28 Euro-Celtique S.A. Pharmaceutical formulation containing bittering agent
WO2003024430A1 (en) 2001-09-21 2003-03-27 Egalet A/S Morphine polymer release system
DE10252667A1 (de) 2002-11-11 2004-05-27 Grünenthal GmbH Spirocyclische Cyclohexan-Derivate
ES2307003T3 (es) 2003-03-26 2008-11-16 Egalet A/S Composiciones matriciales para el suministro controlado de sustancias medicamentosas.
DE10361596A1 (de) 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
WO2005016313A1 (de) 2003-08-06 2005-02-24 Grünenthal GmbH Gegen missbrauch gesicherte darreichungsform
DE102005005446A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
DE10336400A1 (de) 2003-08-06 2005-03-24 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
DE10360792A1 (de) 2003-12-23 2005-07-28 Grünenthal GmbH Spirocyclische Cyclohexan-Derivate
WO2005102286A1 (de) 2004-04-22 2005-11-03 Grünenthal GmbH Verfahren zur herstellung einer gegen missbrauch gesicherten, festen darreinchungsform
WO2006002883A1 (de) 2004-07-01 2006-01-12 Grünenthal GmbH Verfahren zur herstellung einer gegen missbrauch gesicherten, festen darreichungsform unter verwendung eines planetwalzenextruders
EP1765303B2 (de) 2004-07-01 2022-11-23 Grünenthal GmbH Gegen missbrauch gesicherte, oral tablette
PL1786403T3 (pl) 2004-07-01 2013-10-31 Gruenenthal Gmbh Doustna postać dawki zabezpieczona przed nadużywaniem zawierająca (1R, 2R)-3-(3-dimetyloamino-1-etylo0-2-metylo-propylo)fenol
JP4563787B2 (ja) * 2004-12-10 2010-10-13 日立プラズマディスプレイ株式会社 プラズマディスプレイ装置及びその制御方法
DE102005005449A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
JP5161075B2 (ja) 2005-06-03 2013-03-13 エガレット エイ／エス 分散媒体の第１フラクションとマトリックスの第２フラクションを有し、第２フラクションが胃腸の液体に少なくとも部分的に最初に曝される固形の医薬組成物
US20100172989A1 (en) 2006-01-21 2010-07-08 Abbott Laboratories Abuse resistant melt extruded formulation having reduced alcohol interaction
US20090022798A1 (en) * 2007-07-20 2009-01-22 Abbott Gmbh & Co. Kg Formulations of nonopioid and confined opioid analgesics
MX2008009267A (es) * 2006-01-21 2008-10-09 Abbott Gmbh & Co Kg Forma farmaceutica y metodo para la administracion de farmacos de abuso.
US20090317355A1 (en) * 2006-01-21 2009-12-24 Abbott Gmbh & Co. Kg, Abuse resistant melt extruded formulation having reduced alcohol interaction
CA2930487A1 (en) 2007-01-16 2008-07-24 Egalet Ltd. Use of i) a polyglycol and ii) an active drug substance for the preparation of a pharmaceutical composition for i)mitigating the risk of alcohol induced dose dumping and/or ii) reducing the risk of drug abuse
DE102007011485A1 (de) 2007-03-07 2008-09-11 Grünenthal GmbH Darreichungsform mit erschwertem Missbrauch
WO2008132707A1 (en) * 2007-04-26 2008-11-06 Sigmoid Pharma Limited Manufacture of multiple minicapsules
EP2155167A2 (en) 2007-06-04 2010-02-24 Egalet A/S Controlled release pharmaceutical compositions for prolonged effect
EP2249811A1 (en) 2008-01-25 2010-11-17 Grünenthal GmbH Pharmaceutical dosage form
CN107028908A (zh) * 2008-10-27 2017-08-11 阿尔扎公司 对乙酰氨基酚/曲马多口服延释剂型
US20100203129A1 (en) 2009-01-26 2010-08-12 Egalet A/S Controlled release formulations with continuous efficacy
WO2010088911A1 (en) 2009-02-06 2010-08-12 Egalet A/S Pharmaceutical compositions resistant to abuse
CA2766179A1 (en) 2009-06-24 2010-12-29 Egalet Ltd. Controlled release formulations
PE20121067A1 (es) * 2009-07-22 2012-09-05 Gruenenthal Chemie Forma de dosificacion de liberacion controlada extruida por fusion en caliente
PT2838512T (pt) * 2012-04-18 2018-11-09 Gruenenthal Gmbh Forma farmacêutica resistente à adulteração e resistente à libertação inesperada de alta quantidade (dose-dumping)
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc

Similar Documents

Publication Publication Date Title
JP2015147774A5 (enExample)
JP2013173781A5 (enExample)
JP2016503708A5 (enExample)
CN109843873A (zh) 炔代杂环化合物、其制备方法及其在医药学上的应用
EP4249055A3 (en) Tofacitinib oral sustained release dosage forms
JP2013173782A5 (enExample)
JP2014237817A5 (enExample)
JP2017505494A5 (enExample)
EA201201202A1 (ru) Пероральная фармацевтическая композиция, содержащая этексилат дабигатрана
WO2014153495A9 (en) Novel stat3 inhibitors
JP2018530581A5 (enExample)
JP2017197541A5 (enExample)
JP2015529327A5 (enExample)
JP2017147380A5 (enExample)
JP2016540798A5 (enExample)
JP2017077228A5 (ja) 移動式搾乳装置および該移動式搾乳装置を使用した放牧方法
CN105764509A (zh) 达比加群酯或其盐的投药制剂及其制备方法
JP2019518052A5 (enExample)
JP2016531187A5 (enExample)
JP2015208765A5 (enExample)
JP2014239805A5 (enExample)
刘倩君 Gable City
Puhr Finding Contentment Somewhere between Jean-Paul Sartre and the Huainanzi
宋炯炯 The First Piano Sonata of Rachmaninoff
张静利 A Study on The Construction of Corporate Citizenship Image in CSR Reports from The Perspective of Appraisal Theory